1 / 7

2013 Loveland Agri Products Trial Data

2013 Loveland Agri Products Trial Data. Narromine Wheat Seed Treatment Trial. Location:. “BUDDAH” Narromine central NSW. Co-operators:. Loveland . Plot Size:. 10m X 1.76m . Replicates:. 4 . Sowing date:. 7th May. Sowing rate:. 50 kg/ha.

anka
Download Presentation

2013 Loveland Agri Products Trial Data

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. 2013 Loveland Agri Products Trial Data Narromine Wheat Seed Treatment Trial

  2. Location: “BUDDAH” Narromine central NSW Co-operators: Loveland Plot Size: 10m X 1.76m Replicates: 4 Sowing date: 7th May Sowing rate: 50 kg/ha Soil Moisture & Type: Dry Clay loam 6.5 ph, 19.45 C (soil temp) Sakura 118gm/ha (100lt/ha application rate) IBS General Comments: using primary sales tynes, 4.5km/h 41% RH 22 deg C NE breeze. Sprayed 11am sowing commenced 11.30am. CV: Gregory nd Urea applied 2 August Z 30 Trial Setup

  3. Trial Protocol

  4. Yield T/ha LSD (P=.05) = .328 CV = 7.15

  5. Yield T/ha LSD (P=.05) = .328 CV = 7.15

  6. Narromine Rainfall 2012 Total = 420 mm 2013 Total = 455 mm mm

  7. Trial established as a network request to evaluate Awaken ST +- 2 sources of starter fertiliser. Treatments 5-8 mirrored 1-4 plus Urea. The addition of Awaken ST improved treatments in all but 1 treatment. The variety (EGA Gregory) is typically high yielding but low in protein. Awaken ST applied to wheat in central NSW would be a commercially viable treatment. Conclusions

More Related